Gilead disputes report that its drug flopped in leaked coronavirus trial
In the Chinese trial remdesivir, given by intravenous infusion, failed to improve patients’ condition or reduce the pathogen’s…
Author
Blood-pressure drugs are in the crosshairs of COVID-19 research
A disproportionate number of patients hospitalised by COVID-19, the disease caused by the virus, have high blood pressure
Hydroxychloroquine for coronavirus shows no benefit, possible harm in study awaiting validation
An analysis of Veterans Health Administration (VA) data found that 28 per cent of 97 patients given hydroxychloroquine along with…
‘A disaster’: Roche CEO’s verdict on some COVID-19 antibody tests
While most of Roche’s coronavirus activity has been focused on testing, it is also studying if its older arthritis drug Actemra…
Israel’s OurCrowd leads $12 million investment to develop COVID-19 vaccine
MigVax, an affiliate of the Migal Galilee Research Institute, is pioneering the effort to develop a vaccine against COVID-19,…
Bristol Myers says Opdivo performs well in kidney, lung cancer trials
Opdivo is one of Bristol’s top-selling drugs, but sales of the drug have slowed in recent years as it has been eclipsed by Merck…
Novartis to test efficacy of old malaria drug against COVID-19
The company hopes to have data on its efficacy by June, a lead researcher for the trial told Reuters
Institutional investors tell Big Pharma to cooperate on coronavirus
The investor group plan to send pharma companies a list of principles it wants them to abide by for the coming year…
Report says COVID-19 patients respond to Gilead’s remdesivir
A medical news website reported that UChicago Medicine recruited 113 people with severe COVID-19 into Gilead’s trial. It said most…
FDA may have dropped standards too far in hunt for chloroquine to fight coronavirus: Sources
Bayer has donated three million tablets of the drug, called Resochin, to the US national stockpile for treatment of COVID-19.…